Promising PTSD drug moves to Long-Term safety study
NCT ID NCT07670702
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing the long-term safety and effectiveness of a drug called TSND-201 for adults with PTSD. Participants who completed an earlier blinded trial of TSND-201 can receive up to three treatment courses over 48 weeks, each consisting of four weekly doses. The goal is to see if the drug can reduce PTSD symptoms over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TSND-201 (a drug taken as capsules once a week for four weeks per treatment course)
What this could lead to
If it works, this could provide a new treatment option for PTSD that reduces symptoms over the long term.
What could go wrong
This is an open-label extension study, meaning everyone knows they are getting the drug, which can bias results. It is also limited to people who already tolerated the drug in a prior trial, so side effects or lack of benefit in a broader population are still possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST TRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CNS Healthcare
Orlando, Florida, 32801, United States